Standard BioTools Inc. , together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.
Standard Biotools stock last closed at $1.42, up 2.9% from the previous day, and has decreased 17.92% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.28 percentage points. Standard Biotools stock is currently +54.35% from its 52-week low of $0.92, and -38.79% from its 52-week high of $2.32.
At the moment, there are 382M LAB shares outstanding. The market cap of LAB is $542.43M. In the past 24 hours, 974,000 LAB shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy LAB shares.
Based on our experience, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal information so you are able to buy LAB today.
Now that you have opened your account on the best stock trading app, your next step is to transfer the money for your investment:
Watch the video below for more details depositing funds into your new brokerage account.
Once you have figured out the best place to buy Standard Biotools stock, it's crucial to evaluate their stock before you invest, so you actually comprehend the risk and upside.
WallStreetZen was built to help average investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on LAB's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge LAB's fair value.
Using relative valuations measures:
You can access more valuation analysis on LAB's stock here.
You can dive deeper into what analysts are forecasting on the Standard Biotools stock forecast page.
Last year, LAB revenue was $154.24M. Over the last 5 year, LAB's revenue has gone up by 6.49% per year. This was slower than the Diagnostics & Research industry average of 9.53%.
Dig into LAB's earnings and revenue performance here.
In the past year, insiders at LAB have bought more shares than they have sold.
Casdin Partners Master Fund LP, Director of LAB, was the latest LAB insider to buy. They bought $128,900.00 worth of LAB stock on Sep 9, 2025.
Research more about who owns LAB shares here.
No, Standard Biotools doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two primary options:
Click the Open Trade button and your broker will execute your order.
If you need more help with investing in stocks on eToro, watch the how to video below:
Now that you own some LAB shares, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to keep tabs on your LAB stock.
To summarize, here are the 6 steps to buy Standard Biotools stock:
If you need a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep an eye on your new investment in Standard Biotools, hit the button below to create your watchlist.